DiaSorin Investor Relations Material
Latest events
Q3 2024
DiaSorin
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from DiaSorin S.p.A.
Access all reports
Segment Data
Access more data
Revenue by
Geography
North America
Italy
Europe
RoW
Expenses by
Financials
DiaSorin S.p.A. develops, manufactures, and distributes immunodiagnostic and molecular diagnostics testing kits. It offers reagents, analyzers, calibrators, test strips, and automated instruments; reagent kits for autoimmune diseases for laboratory in-vitro diagnostic use; reagents for the diagnosis of syphilis and HIV infections; kits for determining the level of hepatitis B, C, D, and E viruses; and enzymatic tests for assessment of liver function. The company also provides penicillins autoantibodies tests ; HLA autoantibodies tests; anti-ds-DNA autoantibodies; anti-COMP autoantibodiestests; thyroid autoantibodies tests; tumor markers tests; hematology tests; diabetes assays ; monoclonal antibodies ; and specialty diagnostics for rare disorders.
Key slides for DiaSorin S.p.A.
Q1 2024
DiaSorin S.p.A.
Q2 2024
DiaSorin S.p.A.
Latest articles
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
Mips: The Gore-Tex of Brain Protection
How Mips turned a critical safety flaw into a global success, redefining helmet protection with its technology and ingredient brand business model.
24 Jan 2025
Ticker symbol
DIA
Country
🇮🇹 Italy